Literature DB >> 33271362

A pathway to cure chronic infection with Toxoplasma gondii through immunological intervention.

Yasuhiro Suzuki1.   

Abstract

Toxoplasma gondii, an obligate intracellular protozoan parasite, can establish a chronic infection in the brain by forming tissue cysts. This chronic infection is widespread in humans worldwide including developed countries, with up to one third of the population being estimated to be infected with this parasite. Diagnosis of this chronic infection is usually conducted by serological detection of IgG antibodies against this parasite. Since infected individuals remain positive for these antibodies for years, it has generally been considered that this infection is a lifelong infection. It is also often considered that this chronic infection is "latent" or "quiescent". However, recent discovery of the capability of perforin-dependent, CD8+ T cell-mediated immune responses to eliminate T. gondii cysts in collaboration with phagocytes illustrated dynamic interplays between T. gondii cysts and host immune system during this chronic infection. Importantly, the cytotoxic T cell-mediated protective immunity is able to remove mature cysts of the parasite. It is now clear that chronic T. gondii infection is not "latent" or "quiescent". Elucidating the mechanisms of the dynamic host-pathogen interactions between the anti-cyst protective immunity and T. gondii cysts and identifying the pathway to appropriately activate anti-cyst CD8+ cytotoxic T cells would be able to open a door for eradicating T. gondii cysts and curing chronic infection with this parasite.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CD8(+) cytotoxic T cells; Chronic infection; Cyst; Persistence; The protective immunity; Toxoplasma gondii

Mesh:

Year:  2020        PMID: 33271362      PMCID: PMC7878330          DOI: 10.1016/j.parint.2020.102259

Source DB:  PubMed          Journal:  Parasitol Int        ISSN: 1383-5769            Impact factor:   2.230


  26 in total

1.  Toxoplasma gondii infection in cancer patients: prevalence, risk factors, genotypes and association with clinical diagnosis.

Authors:  Wei Cong; Guo-Hua Liu; Qing-Feng Meng; Wei Dong; Si-Yuan Qin; Fu-Kai Zhang; Xiang-Yan Zhang; Xiang-Yang Wang; Ai-Dong Qian; Xing-Quan Zhu
Journal:  Cancer Lett       Date:  2015-01-29       Impact factor: 8.679

Review 2.  Immunology of Toxoplasma gondii.

Authors:  Melba Munoz; Oliver Liesenfeld; Markus M Heimesaat
Journal:  Immunol Rev       Date:  2011-03       Impact factor: 12.988

3.  Determination of a Key Antigen for Immunological Intervention To Target the Latent Stage of Toxoplasma gondii.

Authors:  Qila Sa; Eri Ochiai; Ashish Tiwari; Jeremi Mullins; Nilabh Shastri; Corinne Mercier; Marie-France Cesbron-Delauw; Yasuhiro Suzuki
Journal:  J Immunol       Date:  2017-04-26       Impact factor: 5.422

4.  An ultrastructural study of the early development and tissue cyst formation of Toxoplasma gondii in the brains of mice.

Authors:  D J Ferguson; W M Hutchison
Journal:  Parasitol Res       Date:  1987       Impact factor: 2.289

Review 5.  Host resistance to Toxoplasma gondii: model for studying the selective induction of cell-mediated immunity by intracellular parasites.

Authors:  R T Gazzinelli; E Y Denkers; A Sher
Journal:  Infect Agents Dis       Date:  1993-06

6.  CD8(+) T cells remove cysts of Toxoplasma gondii from the brain mostly by recognizing epitopes commonly expressed by or cross-reactive between type II and type III strains of the parasite.

Authors:  Eri Ochiai; Qila Sa; Sara Perkins; Michael E Grigg; Yasuhiro Suzuki
Journal:  Microbes Infect       Date:  2016-04-12       Impact factor: 2.700

7.  Incidence of adult brain cancers is higher in countries where the protozoan parasite Toxoplasma gondii is common.

Authors:  Frédéric Thomas; Kevin D Lafferty; Jacques Brodeur; Eric Elguero; Michel Gauthier-Clerc; Dorothée Missé
Journal:  Biol Lett       Date:  2011-07-27       Impact factor: 3.703

8.  Interferon-gamma: the major mediator of resistance against Toxoplasma gondii.

Authors:  Y Suzuki; M A Orellana; R D Schreiber; J S Remington
Journal:  Science       Date:  1988-04-22       Impact factor: 47.728

9.  Removal of Toxoplasma gondii cysts from the brain by perforin-mediated activity of CD8+ T cells.

Authors:  Yasuhiro Suzuki; Xisheng Wang; Benard S Jortner; Laura Payne; Yanyan Ni; Sara A Michie; Baohui Xu; Tomoya Kudo; Sara Perkins
Journal:  Am J Pathol       Date:  2010-02-18       Impact factor: 4.307

10.  Aging with Toxoplasma gondii results in pathogen clearance, resolution of inflammation, and minimal consequences to learning and memory.

Authors:  Kathryn E McGovern; Carla M Cabral; Helena W Morrison; Anita A Koshy
Journal:  Sci Rep       Date:  2020-05-14       Impact factor: 4.379

View more
  2 in total

1.  Sulfadiazine Plus Pyrimethamine Therapy Reversed Multiple Behavioral and Neurocognitive Changes in Long-Term Chronic Toxoplasmosis by Reducing Brain Cyst Load and Inflammation-Related Alterations.

Authors:  Barrios Leda Castaño; Andrea Alice Silva; Lina L Hernandez-Velasco; Ana Paula Da Silva Pinheiro; Daniel Gibaldi; José Roberto Mineo; Neide Maria Silva; Joseli Lannes-Vieira
Journal:  Front Immunol       Date:  2022-04-27       Impact factor: 8.786

2.  Single Cell Transcriptomes of In Vitro Bradyzoite Infected Cells Reveals Toxoplasma gondii Stage Dependent Host Cell Alterations.

Authors:  Tatsuki Sugi; Tadakimi Tomita; Taishi Kidaka; Naoko Kawai; Kyoko Hayashida; Louis M Weiss; Junya Yamagishi
Journal:  Front Cell Infect Microbiol       Date:  2022-03-14       Impact factor: 5.293

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.